Published

Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Scientific reports
Date: 2019-10-24
Source: PubMed
DOI: 10.1038/s41598-019-50612-3
PubMed: 31649304

Authors

Smigielski L Kometer M Scheidegger M Krähenmann R Huber T Vollenweider FX

Watch author

Derived topics and classifications

psilocybin Anxiety Mechanism of Action Emotional Processing Drug Interactions Other

Citation graph

0 referenced DOIs found in stored source metadata. 7 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model2026-12-01 DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish2026-06-18 Does Psychological Flexibility Correlate with Mystical Experiences: A Machine Learning Approach Including State of Surrender, Near-Death Experiences, and Psilocybin Consumption2026-04-30 A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience2026-04-14 Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01 Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications2026-03-01 Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.2019-10-24

Related papers

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20 Maddening Therapies: How Hallucinogens Morphed into Novel TreatmentsCurrent psychiatry · 2017-01-01 Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2014-05-20 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17